Maxim Group Cuts KindlyMD (NASDAQ:NAKA) Price Target to $0.75

KindlyMD (NASDAQ:NAKA) had its price target reduced by Maxim Group from $1.50 to $0.75 in a research note released on Monday,Benzinga reports. They currently have a buy rating on the stock.

A number of other research analysts also recently issued reports on NAKA. Weiss Ratings reiterated a “sell (e+)” rating on shares of KindlyMD in a research note on Friday, March 27th. B. Riley Financial decreased their price target on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating for the company in a research note on Monday, February 23rd. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, KindlyMD presently has an average rating of “Hold” and an average price target of $0.63.

KindlyMD Stock Down 0.8%

Shares of KindlyMD stock opened at $0.21 on Monday. KindlyMD has a 52-week low of $0.21 and a 52-week high of $34.77. The company has a 50 day moving average of $0.26 and a 200 day moving average of $0.51. The company has a market capitalization of $145.25 million, a P/E ratio of -0.24 and a beta of 26.73.

Institutional Trading of KindlyMD

Several institutional investors have recently modified their holdings of the stock. Sagespring Wealth Partners LLC acquired a new position in shares of KindlyMD in the 4th quarter valued at $28,000. SG Americas Securities LLC acquired a new position in shares of KindlyMD in the 4th quarter valued at $61,000. Virtu Financial LLC acquired a new position in shares of KindlyMD in the 4th quarter valued at $151,000. J. Derek Lewis & Associates Inc. acquired a new position in shares of KindlyMD in the 4th quarter valued at $167,000. Finally, Truist Financial Corp acquired a new position in shares of KindlyMD in the 4th quarter valued at $176,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.